Hisamitsu Pharmaceutical Co (TSE:4530) Other Stockholders Equity : 円52,489 Mil (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Other Stockholders Equity?

Hisamitsu Pharmaceutical Co's Other Stockholders Equity for the quarter that ended in Nov. 2023 was 円52,489 Mil.

Hisamitsu Pharmaceutical Co's quarterly Other Stockholders Equity increased from May. 2023 (円39,435 Mil) to Aug. 2023 (円49,804 Mil) and increased from Aug. 2023 (円49,804 Mil) to Nov. 2023 (円52,489 Mil).

Hisamitsu Pharmaceutical Co's annual Other Stockholders Equity increased from Feb. 2022 (円25,671 Mil) to Feb. 2023 (円37,155 Mil) and increased from Feb. 2023 (円37,155 Mil) to Feb. 2024 (円48,452 Mil).

Hisamitsu Pharmaceutical Co Other Stockholders Equity Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Other Stockholders Equity Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Other Stockholders Equity

Get a 7-Day Free Trial

19,327.00

19,589.00

25,671.00

37,155.00

48,452.00

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Other Stockholders Equity	Get a 7-Day Free Trial															37,155.00	39,435.00	49,804.00	52,489.00	48,452.00

Hisamitsu Pharmaceutical Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Hisamitsu Pharmaceutical Co Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines